News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
124 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44432)
2016 (38329)
2017 (37188)
2018 (39119)
2019 (51334)
2020 (57663)
2021 (58720)
2022 (53928)
2023 (42564)
2024 (37441)
2025 (33091)
2026 (18644)
Month
January (3098)
February (3516)
March (3513)
April (3269)
May (4089)
June (3205)
July (2932)
August (3176)
September (2859)
October (3385)
November (3129)
December (2245)
Day
1 (171)
2 (182)
3 (149)
4 (162)
5 (103)
8 (133)
9 (169)
10 (133)
11 (155)
12 (96)
15 (156)
16 (164)
17 (139)
18 (162)
19 (104)
22 (161)
23 (156)
24 (175)
25 (168)
26 (139)
29 (142)
30 (124)
31 (142)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
8
9
10
11
12
15
16
17
18
19
22
23
24
25
26
29
30
31
Drug Development
Ocular Therapeutix, Inc. Demonstrates Two-Month IOP Reduction With Sustained Release Travoprost for the Treatment of Glaucoma
October 30, 2012
·
3 min read
Pharm Country
Albany Molecular Research, Inc. (AMRI) to Announce Third Quarter Results
October 30, 2012
·
1 min read
Pharm Country
Boehringer Ingelheim Pharmaceuticals, Inc. to Present Interim Safety and Efficacy Data for Pradaxa® (Dabigatran Etexilate Mesylate) in Longer-Term Use at the American Heart Association’s Scientific Sessions
October 30, 2012
·
9 min read
Business
CryoLife, Inc. Reports 13% Revenue Growth for Third Quarter 2012
October 30, 2012
·
1 min read
Business
Parker Hannifin Corporation Signs Licensing Agreement With Vanderbilt University for Exoskeleton Technology and Targets Commercial Launch in 2014
October 30, 2012
·
5 min read
Biotech Beach
Reflexion Health Raises $4.5 Million to Advance Idea for “Prescribed Software”
October 30, 2012
·
1 min read
FDA
Sequana Medical Receives CE-Mark Approval for the Use of Its alfapump® System in Cancer Patients With Malignant Ascites
October 30, 2012
·
2 min read
Pharm Country
PDI, Inc. to Hold Third Quarter 2012 Financial Results Conference Call on Tuesday, November 6, 2012
October 30, 2012
·
1 min read
FDA
Smiths Medical, Inc. Release: CE Clearance for New Safety IV Catheter
October 30, 2012
·
2 min read
Policy
Orthofix International NV Settles Blackstone Medical Inc. Beef With Feds for $32 Million
October 30, 2012
·
3 min read
Previous
6 of 13
Next